dailypolitical.com
Positivewww.dailypolitical.com ·
Becton Dickinson and Company Bdx Position Trimmed by Lazard Freres Gestion S a S
CorruptionAnalystHealth TechnologiesHealth Nutrition And Populati…
Topic context
This topic has been covered 309829 times in the last 30 days across our monitored publishers.
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedInstitutional portfolio rebalancing in BDX (medical device manufacturer). No direct commercial mechanism (no supply/demand/regulatory shock). Weak signal: insider selling vs. buying by other funds. No product price or margin impact.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- Lazard Freres Gestion S.A.S. reduced BDX stake by 18.7% in Q4.
- BDX reported Q2 2026 EPS of $2.90, beating estimates.
- BDX revenue $4.71B, +5.2% YoY.
- Quarterly dividend $1.05 payable June 30, 2026.
- Other institutional investors increased stakes.
